Literature DB >> 21185561

Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: a meta-analysis.

Xiao Huang1, Jiangpei Zhao, Tongfeng Zhao.   

Abstract

OBJECTIVE: Results from the published studies on the association of peroxisome proliferator activated receptor-gamma 2 (PPARγ2) Pro12Ala polymorphism with blood lipids are conflicting. In this meta-analysis, we investigated the association of the Pro12Ala polymorphism with total cholesterol, triglycerides, low density lipoprotein cholesterol, and high-density lipoprotein cholesterol.
METHODS: 74 studies with 52,998 subjects were included in this meta-analysis. Dominant model and additive model were used for this meta-analysis.
RESULTS: We did not detect significant overall association of the Pro12Ala polymorphism with total cholesterol, low density lipoprotein cholesterol, or high-density lipoprotein cholesterol (P>0.05). Under dominant model, significant association between the PPARγ2 Pro12Ala polymorphism and increased blood TC in male subjects was detected: standardized mean difference=0.10, 95% confidence interval (0.02, 0.22), P=0.02, Pheterogeneity=0.14. We found a marginal association of the Pro12Ala polymorphism with increased HDL-C in healthy subjects under dominant model: standardized mean difference=0.10, 95% confidence interval (-0.00, 0.20), P=0.06, Pheterogeneity=0.96. We also found subjects with genotype AlaAla have lower blood TG than subjects with genotype ProPro in Caucasians: for analysis including the outlier studies: SMD=-0.40, 95% CI (-0.76, -0.05), P=0.02, Pheterogeneity<0.00001, and for analysis excluding the outlier studies: SMD=-0.23, 95% CI (-0.39, -0.06), P=0.006, Pheterogeneity=0.86.
CONCLUSIONS: Our meta-analysis suggests that, compared with non-carriers, carriers of Ala allele have significant increased blood TC in male subjects, and marginally significant increased blood HDL-C in healthy subjects. Our meta-analysis also supports that subjects with genotype AlaAla have lower blood TG than subjects with genotype ProPro in Caucasians.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185561     DOI: 10.1016/j.atherosclerosis.2010.11.043

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Dietary polyunsaturated fatty acids and the Pro12Ala polymorphisms of PPARG regulate serum lipids through divergent pathways: a randomized crossover clinical trial.

Authors:  Jussi Pihlajamäki; Ursula Schwab; Dorota Kaminska; Jyrki Ågren; Johanna Kuusisto; Marjukka Kolehmainen; Jussi Paananen; Markku Laakso; Matti Uusitupa
Journal:  Genes Nutr       Date:  2015-10-07       Impact factor: 5.523

2.  Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.

Authors:  Jinlan Ma; Yan Li; Fang Zhou; Xiaoyi Xu; Gang Guo; Yi Qu
Journal:  Mol Vis       Date:  2012-09-10       Impact factor: 2.367

3.  PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study.

Authors:  Pilar García-Broncano; Juan Berenguer; Amanda Fernández-Rodríguez; Daniel Pineda-Tenor; María Ángeles Jiménez-Sousa; Mónica García-Alvarez; Pilar Miralles; Teresa Aldámiz-Echevarria; Juan Carlos López; Dariela Micheloud; Salvador Resino
Journal:  J Transl Med       Date:  2014-08-27       Impact factor: 5.531

4.  Polymorphisms of the PPAR-γ (rs1801282) and Its Coactivator (rs8192673) Have a Minor Effect on Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus.

Authors:  Aleš Pleskovič; Marija Šantl Letonja; Andreja Cokan Vujkovac; Jovana Nikolajević Starćević; Danijel Petrovič
Journal:  PPAR Res       Date:  2016-02-02       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.